title: Topical 5-fluorouracil in Darier disease.
authors.forename: H
authors.initials: H
authors.lastname: Schmidt
authors.forename: F R
authors.initials: FR
authors.lastname: Ochsendorf
authors.forename: M
authors.initials: M
authors.lastname: Wolter
authors.forename: G
authors.initials: G
authors.lastname: Geisslinger
authors.forename: R J
authors.initials: RJ
authors.lastname: Ludwig
authors.forename: R
authors.initials: R
authors.lastname: Kaufmann
mesh_terms: D000328:Adult; D000368:Aged; D007644:Darier Disease / Q000188:drug therapy*; D004333:Drug Administration Routes; D005260:Female; D005472:Fluorouracil / Q000008:administration & dosage*; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage*; D008297:Male; D008875:Middle Aged; D013940:Thymidylate Synthase / Q000378:metabolism; D016896:Treatment Outcome
chemical_list: D007166:Immunosuppressive Agents; D013940:Thymidylate Synthase; D005472:Fluorouracil